San Francisco Sentry Investment Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-11
Closed -$1K 668
2020
Q1
$1K Hold
11
﹤0.01% 705
2019
Q4
$1K Hold
11
﹤0.01% 787
2019
Q3
$1K Buy
+11
New +$1K ﹤0.01% 786
2018
Q4
Sell
-10
Closed -$1K 969
2018
Q3
$1K Buy
+10
New +$1K ﹤0.01% 824